Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationMRC prizes 2022: Nominations are now open
UKRI budget allocation confirmed
ANSM issues revised French GVPs
Analytical Procedures for mRNA Vaccine Quality (Draft Guidelines) Type of Posting: General Announcement Posting Date: 10–Feb–2022 Input Deadline: 30–Jun–2022 Expert Committee: Biologics Monograph 3 – Complex Biologics & Vaccines Proposed Title: Analytical Procedures for mRNA Vaccine Quality (Draft Guidelines)
EMA - Gerrit Johan Schefferlie elected new Chair of EMA Committee for Veterinary Medicinal Products (CVMP)
EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 May 2022
EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 May 2022
From the EMA Stakeholder engagement biennial report 2020-2021 and highlights of stakeholder activities in 2021 We are pleased to inform you that the biennial stakeholder engagement report has been published, along with the highlights of stakeholder activities in 2021. This report provides a high-level overview of EMA's engagement with patients, consumers, healthcare professionals and academia and different activities where they have been involved. EMA would like to thank all stakeholders involved in activities during these two challenging years. This biennial report has also been shared by social media, the links are below:
MHRA: policy for handling conflicts of interest - Uploaded the annual conflict of interest compliance report - 2021
MHRA - Uploaded the Drug Safety Update for May 2022